The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion.
about
Diagnosis and Novel Approaches to the Treatment of Hypereosinophilic Syndromes.Splanchnic vein thrombosis in myeloproliferative neoplasms: treatment algorithm 2018.Challenges in the introduction of next-generation sequencing (NGS) for diagnostics of myeloid malignancies into clinical routine useGenetic predictors of response to specific drugs in primary myelofibrosisThe Development of Serum Amyloid P as a Possible Therapeutic
P2860
The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
The 2016 WHO classification an ...... mmary and in-depth discussion.
@en
The 2016 WHO classification an ...... mmary and in-depth discussion.
@nl
type
label
The 2016 WHO classification an ...... mmary and in-depth discussion.
@en
The 2016 WHO classification an ...... mmary and in-depth discussion.
@nl
prefLabel
The 2016 WHO classification an ...... mmary and in-depth discussion.
@en
The 2016 WHO classification an ...... mmary and in-depth discussion.
@nl
P2093
P2860
P1433
P1476
The 2016 WHO classification an ...... mmary and in-depth discussion.
@en
P2093
Alessandro M Vannucchi
Attilio Orazi
Hans Michael Kvasnicka
Heinz Gisslinger
Jürgen Thiele
Tiziano Barbui
P2860
P2888
P356
10.1038/S41408-018-0054-Y
P5008
P577
2018-02-09T00:00:00Z
P6179
1100922113